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Abstract
Background: The percent absorption of lutein from supplements falls well below that from lutein enriched egg
yolk, a rich source of phospholipids. Therefore, a supplement of lutein plus phospholipids was tested for effects on
serum accumulation.
Methods: A 10 day supplementation with a solid-lipid particle (SLP™) lutein complex or conventional lutein ester
was done in apparently healthy people (both supplement types taken with fat containing meals). Plasma lutein was
measured pre- and post-supplementation as well as 7 days after supplementation stopped. Changes within each
supplement group were analyzed by paired t-test; group comparisons were done by unpaired t-test.
Results: The solid-lipid particle complex lutein gave much higher plasma lutein values than conventional lutein
ester. The lutein complex showed superior effects based on absolute mean value after 10 days of supplementation,
change in value from baseline to 10 days, and value at 7 days after supplement discontinuation.
Conclusions: A solid lipid lutein complex strongly increased plasma lutein levels compared to a conventional form.
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Introduction
Lutein, a member of the carotenoid family, is a non-
essential nutrient that has shown ability to accumulate
in the eye, perform antioxidant actions relevant to
protection of the eye, affect macular pigment density,
and improve multifocal electroretinogram response in
people with macular degeneration (reviewed in [1]).
Also, diets high in carotenoids that include lutein
show an inverse correlation with aging related eye
problems (reviewed in [1]).
Lutein can be obtained from foods as well as from nu-
tritional supplements. Lutein ester from enriched egg
yolk has displayed superior absorption than lutein from
certain vegetable or supplement sources [2]. In a later
study [3], a 90 day intake of 1 mg/day of lutein in
enriched eggs is claimed to produce the same serum
lutein as 5 mg of lutein as a supplement.
Although the amount of lutein per serving of normal
eggs falls far below that of a few vegetable sources, egg
consumption have been found to raise serum lutein
readings [4, 5]. Presumably, this effect of eggs occurs
due to the strong absorption of lutein ester from this
source. These observations raise the question: Can an
especially effective supplement be made by complexing
lutein with phospholipids and fatty acids that overlaps
those of eggs? Therefore, a pilot study was conducted to
evaluate plasma accumulation of such a complex com-
pared to a conventional lutein.
Methods and materials
The study protocol was approved by the OhioHealth In-
stitutional Review Board. All subjects signed an in-
formed consent form. Subjects were 12 males and
females (six of each gender) aged 52 to 69, mean ± SD
of 57 ± 3 for the standard lutein, and 59 ± 6 for the novel
lutein complex. Based on answers to an eligibility ques-
tionnaire, the accepted subjects were nonsmokers who
were free from problems that cause widespread oxidant
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stress or cause problems with absorption of lipid nutri-
ents. Also, based on answers to the questionnaire, sub-
jects did not consume eggs, spinach, or kale more than
four times a month, nor take lutein supplements.
Subjects were randomly assigned to either lutein ester
or a solid-lipid particle (SLP™) complex lutein. The latter
was supplied by Verdure Sciences, Noblesville, IN, USA.
The subjects took a single capsule of 10 mg lutein for
10 days (same mg of lutein/day/treatment, though differ-
ent weights of total powder). Subjects were blinded to
group assignment. The capsules were taken with a self-
selected meal containing at least 200 Calories of fat. The
subjects provided a blood sample in a heparin containing
tube before and after the 10-day supplementation period
as well as 7 days after discontinuing the supplement.
Plasma was separated by centrifugation for 30 min at
3000 rpm. Plasma lutein was determined by HPLC [6].
Changes within each supplement group were analyzed
by paired t-test using http://www.fon.hum.uva.nl/Ser
vice/Statistics/Student_t_Test.html Group comparisons
were done by unpaired t-test using http://www.fon.hum.
uva.nl/Service/Statistics/2Sample_Student_t_Test.html
Results
After 10 days of supplementation, both supplements
produced highly significant increases in plasma lutein
values (Fig. 1, p < 0.001 for each treatment, paired t-test).
The solid-lipid particle complex lutein gave a much
higher mean plasma lutein value than conventional
lutein (p < 0.001, unpaired t-test). The mean percent
change versus pre-supplement values was 563 % for the
solid-lipid particle complex lutein and 88 % for the
conventional lutein ester. If the data was expressed as
the change in lutein concentrations, a much higher
mean change was seen with the solid-lipid particle com-
plex (Fig. 2, p < 0.001, unpaired t-test). For both the con-
ventional and new lutein supplement, mean plasma
lutein levels remained above baseline 7 days after sup-
plementation (Fig. 1, pre-values vs Fig. 3, p < 0.001,
paired t-test). However, the solid-lipid particle complex
lutein gave a much higher mean plasma lutein value
(Fig. 3, p < 0.001, paired t-test). Thus, by three types of
evaluations, plasma lutein concentrations responded to a
much greater degree to the solid-lipid particle complex
lutein than to a conventional version.
Discussion
In this pilot study, solid-lipid particle complex lutein
clearly produced much higher mean plasma lutein values
than a conventional lutein. Admittedly, a small subject
number was examined. However, even for this small
number, impressively low p values were obtained for the
various comparisons. Moreover, the quantitative differ-
ences reached high proportions and the results were
very consistent among all participants.
In this study, the conventional lutein consisted of an
ester. In one comparison with free lutein, an ester fares
better [7]. In contrast, in two other studies [8, 9], free
lutein produced a better serum response than an ester,
at least for some types of comparison. However, even if
the favorable results for free lutein are considered, the
percent differences for free versus ester don’t come close
to the present study’s results for solid-lipid particle com-
plex versus ester. Thus, the solid-lipid particle complex
Fig. 1 Plasma lutein concentrations before and after 10 days supplementation with 10 mg/day of lutein. Lutein 1 = lutein ester. Lutein 2 = solid-lipid
particle complex lutein. *Significantly different from pre value, p < 0.001, paired t-test
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lutein would likely show much stronger effects than
free lutein.
The higher plasma lutein concentrations produced by
the solid-lipid particle complex lutein is assumed to reflect
better absorption from the GI tract. However, in theory,
the high plasma values could instead reflect poor uptake
into body tissues. Two lines of reasoning make this
unlikely. First, no studies report this type behavior, but
studies have shown increases in serum or plasma lutein to
be accompanied by tissue increases (ie [10–12]). Second,
if this study’s results are due to poor tissue uptake of
the solid-lipid particle complex lutein, this complex
would have to enter intestinal cells well, but not
enter other types of cells well. Nothing in current
Fig. 2 The change in plasma lutein concentrations after 10 days of supplementation with 10 mg/day of lutein. Lutein 1 = lutein ester.
Lutein 2 = solid-lipid particle complex lutein. *Significantly different from pre value, p < 0.002, unpaired t-test
Fig. 3 Plasma lutein concentrations 7 days post-supplementation (10 mg/day of lutein for 10 days). Lutein 1 = lutein ester. Lutein 2 = solid-lipid
particle complex lutein. *Significantly different from Lutein1 value, p < 0.001, unpaired t-test
DiSilvestro et al. Nutrition Journal  (2015) 14:104 Page 3 of 4
knowledge of carotenoid metabolism points to the
possibility of such behavior. It can be further noted
that in many studies on relative lutein absorption,
plasma or serum lutein levels are used as the end-
point (ie [2–5, 7–10]).
A question that could be raised about the current re-
sults is: Do the high plasma lutein concentrations ob-
tained in the present study translate to better eye health?
This cannot be answered yet, but some data suggests
such high concentrations can promote eye health. In a
study on lutein ester supplementation [10], going from 5
to 10 to 20 mg/day increases both serum lutein readings
and macular pigment optical density. Thus, no evidence
was found that macular pigment optical density peaks at
the rises in serum lutein seen in that study. However, for
serum lutein readings in that study, the fold differences
between 10 and 20 mg lutein ester fell way below the
fold differences seen here for 10 mg lutein ester versus
solid-lipid particle complex lutein. Thus, it can be pro-
jected that 10 mg of phospolipidated lutien would likely
more strongly impact macular pigment optical density
than the 20 mg lutein ester used in the previous work.
Therefore, it could be projected that the 10 mg of solid-
lipid particle complex lutein could likely translate into
higher macular pigment optical density readings than
given by the 20 mg of lutein ester studied earlier.
A comparison between the current study and the just
discussed previous study [10] cannot be made based on
absolute values for serum or plasma lutein. Such values
rose much higher in the previous study, but the previous
study used a much longer intervention time.
One question that can arise about the solid-lipid par-
ticle complex lutein is whether the dose of the present
study can produce toxicity. Rodent studies provide evi-
dence against such a possibility. Even when serum lutein
is greatly increased by tremendously high lutein doses,
toxicity is not found [13, 14]. Also, in rabbits, high eleva-
tion of eye lutein levels by direct lutein application does
not cause toxicity [15].
In summary, a 10 day supplementation of solid-lipid
particle complex lutein produced far greater plasma
accumulation than lutein ester. The solid-lipid particle
complex lutein merits consideration for possible use in
eye health supplements.
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